Magnesium infusion and postoperative atrial fibrillation: A randomized clinical trial

Acta Anaesthesiologica Taiwanica

Volumn 45, Issue 2, 2007, Pages 89-94

  Najafi, Mahdi ^a   Hamidian, Reza ^a   Haghighat, Babak ^a   Fallah, Nader ^a   Tafti, Hossein Ahmadi ^a   Karimi, Abbasali ^a   Boroumand, Mohammad Ali ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Anti arrhythmia agents; Atrial flbrillaiton; Coronary artery bypass; Diabetes mellitus; Magnesium

Indexed keywords

MAGNESIUM; MAGNESIUM SULFATE;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BRADYCARDIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DROWSINESS; ELECTROCARDIOGRAM; FEMALE; FLUSHING; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; HYPOTENSION; INTENSIVE CARE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SIDE EFFECT; VOMITING; BLOOD; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

ADULT; AGED; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 34548438967     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Archbold RA, Zaman AG: Magnesium for atrial fibrillation after coronary artery bypass graft surgery: its role in aetiology and prevention. Crit Care Resusc 2:260-268, 2000.
2. Alghamdi AA, Al-Radi OO, Latter DA: Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis. J Card Surg 20:293-299, 2005.
3. Mathew JP, Parks R, Savino, JS Friedman AS, Koch C, Mangano DT, Browner WS: Atrial fibrillation following coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia Research Group. JAMA 276: 300-306, 1996.
4. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56: 539-549, 1993.
5. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Grover FL, Hammermeister KE: Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 226:501-511, 1997.
6. Balser JR: Pharmacologic Management of arrhythmias. In: Estafanous FG, Barash PG, Reves JG. Cardiac anesthesia: principles and clinical practice. 2nd edition, Philadelphia: Lippincott Williams & Wilkins, p103-116, 2001.
7. Hilleman DE, Hunter CB, Mohiuddin SM, Maciejewski S: Pharmacological management of atrial fibrillation following cardiac surgery. Am J Cardiovasc Drugs 5:361-369, 2005.
8. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ Jr, Cohn LH, Burstin HR: Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94:390-397, 1996.
9. Aglio LS, Stanford GG, Maddi R, Boyd JL 3rd, Nussbaum S, Chernow B: Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth 5:201-208, 1991.
10. Gomez MN: Magnesium and cardiovascular disease. Anesthesiology 89:222-240, 1998.
11. Toraman F, Karabulut EH, Alhan HC, Dagdelen S, Tarcan S: Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary Artery bypass grafting. Ann Thorac Surg 72:1256-1262, 2001.
12. England MR, Gordon G, Salem M, Chernow B: Magnesium administration and dysrhythmias after cardiac surgery. JAMA 268:2395-2402, 1992.
13. Brackbill M, Moberg L: Magnesium sulfate for prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Am J Health Syst Pharm 62:397-399, 2005.
14. Miller S, Crystal E, Garfinkle M, Lau C, Lashevsky I, Connolly SJ: Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 91:618-623, 2005.
15. Colquhoun IW, Berg GA, El-Fikey M, Hurle A, Fell GS, Wheatley DJ: Arrhythmia prophylaxis after coronary artery surgery: a randomized controlled trial of intravenous magnesium chloride. Eur J Cardiothorac Surg 7:520-523, 1993.
16. Shirey TL: Monitoring magnesium to guide therapy for heart surgery. J Anesth 18: 118-128, 2004.
17. Fanning WJ, Thomas CS, Roach A, Tomicheck R, Alford WC, Stoney WS: Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg 52:529-533, 1991.
18. 4 replacement. J Card Surg 11:421-427, 1996.
19. Wollert HG, Grossmann H, Eckel L: Magnesium sulfate prevents atrial tachyarrhythmias after cardiac and non-cardiac surgery: what is the common mechanism? J Thorac Cardiovasc Surg 45:213-214, 1997.
20. Yeatman M, Caputo M, Narayan P, Lotto AA, Ascione R, Bryan AJ, Angelini GD: Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization. Ann Thorac Surg 73: 112-118, 2002.
21. Henyan NN, Gillespie EL, White MC, Kliger J, Coleman CI: Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg 80: 2402-2406, 2005.
22. Shiga T, Wajima Z, Inoue T, Ogawa R: Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med 117:325-333, 2004.
23. Kaplan M, Kut MS, Icer UA, Dermitas MM: Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg 125: 344-352, 2003.
24. Parikka H, Toivonen L, Pellinen T, Verkkala K, Jarvinen A, Nieminen MS: The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery bypass operation. Eur Heart J 14: 251-258, 1993.
25. Bert AA, Reinert SE, Singh AK: A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vascu Anesth 15:204-209, 1994.
26. Caspi J, Rudis E, Bar I, Safadi T, Saute M: Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 59:942-947, 1995.
27. Harris MN, Crowther A, Jupp RA, Aps C: Magnesium and coronary revascularization. Br J Anaesth 60:779-783, 1988.
28. Jensen BM, Alstrup P, Klitgard NA: Magnesium substitution and postoperative arrhythmias in patients undergoing coronary artery bypass grafting. Scand Cardiovasc J 31:265-269, 1997.
29. Karmey-Jones R, Hamilton A, Dzavik V, Allegreto M, Finegan BA, Koshal A: Magnesium sulfate prophylaxis after cardiac operations. Ann Thorac Surg 59:502-507, 1995.
30. Schwieger IM, Kopel ME, Finlayson DC: Magnesium and postoperative dysrhythmias in patients after cardiac surgery. J Cardiothorac Anesth 3:18, 1989.
31. Shakerinia T, Ali IM, Sullivan JA: Magnesium in cardioplegia: is it necessary? Can J Surg 1996:397-400, 1996.
32. Treggiari-Venzi MM, Waeber JL, Perneger TV: Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 85:690-695, 2000.
33. Sales CH, Pedrosa LF: Magnesium and diabetes mellitus: their relation. Clin Nutr 25:554-562, 2006.
34. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S: Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem. 238:163-179, 2002.
35. Pun KK, Ho PWM: Subclinical hyponatremia, hypokalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus. Diabetes Res Clin Pract 7:163-167, 1989.
36. Movahed MR, Hashemzadeh M, Jamal MM: Diabetes mellitus is a strong independent risk factor for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 105:315-318, 2005.
37. Lip GYH, Varughese GI: Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Card 105:319-321, 2005.
38. Hastie T, Tibshirani RJ: Generalized additive models. 2nd ed., London: Chapmann & Hall, p1-352, 1990.
39. Klevary LM, Milne DB: Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr 75:550-554, 2002.
40. Roden DM, Iansmith DH: Effects of low potassium or magnesium concentrations on isolated cardiac tissue. Am J Med 82:18-23, 1987.
41. Rasmussen HS, Thomsen PE: The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium and ventricle. Clin Cardiol 12:85-90, 1989.
42. Christiansen EH, Frost L, Andreasen F, Mortensen P, Thomsen PE, Pedersen AK: Dose-related cardiac electrophysiological effects of intravenous magnesium: a double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia. Europace 2:320-326, 2000.
43. Hogue CW Jr, Con: All patients should not receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 13:101-104, 1999.
44. Hilleman D, Miller MA, Parker R, Doering P, Pieper JA: Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 18:138S-45S, 1998.
45. Hazelrigg SR, Boley TM, Cetindag IB, Moulton KP, Trammell GL, Polancic JE, Shawgo TS, Quin JA, Verhulst S: The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting. Ann Thorc Surg 77: 824-830, 2004.
46. Zaman AG, Alaingir F, Richens T, Williams R, Rothman MT, Mills PG: The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 77:527-531, 1997.
47. Dagdelen S, Toraman F, Karabulut H, Yuce M, Alban C: The value of P dispersion on predicting atrial fibrillation after coronary artery bypass surgery, effect of magnesium on P dispersion. Card Electrophysiol Rev 7:162-164, 2003.
48. Takahashi Y, Sanders P, Rotter M, Rostock T, Haissauguerre M: Sinus node region as an ultimate source driving chronic atrial fibrillation. J Cardiovasc Electrophysiol 16:1023, 2005.
49. Tentolouris T, Skouros C, Antonopoulos A, Barbetseas J, Kyriakidis M, Toutouzas P: Early atrial arrhythmias in acute myocardial infarction. Role of the sinus node artery. Chest 101:944-947, 1992.